title: Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.
abstract: mAb4E4, a murine monoclonal antibody that is specific for acetylated LDL and malondialdehyde-treated LDL, binds specifically to modified LDL present in human atherosclerotic lesions. It is directed against an epitope that is poorly exposed in delipidated and solubilized apolipoprotein B-100 from modified LDL. mAb4E4, as well as its F(ab')2 and Fab fragments, enhanced the uptake of both acetylated LDL and malondialdehyde-treated LDL by THP-1-derived macrophages resulting in a sixfold increase of cytoplasmic cholesteryl ester levels. The increased uptake of modified LDL/mAb4E4 complexes did not occur via the Fc receptor and did not depend on aggregation of modified LDL particles. However, their uptake was inhibited by blocking the scavenger receptors with fucoidin or by downregulation of receptor expression with endotoxins or interferon-gamma, indicating that their uptake is mediated via these receptors. Thus, generation of autoimmune antibodies against modified LDL and subsequent endocytosis of soluble modified LDL/antibody complexes via scavenger receptors may enhance foam cell generation. This mechanism may contribute to the progression of atherosclerotic lesions.
authors.affiliation: Center for Molecular and Vascular Biology, University of Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Holvoet
authors.forename: G
authors.initials: G
authors.lastname: Perez
authors.forename: H
authors.initials: H
authors.lastname: Bernar
authors.forename: E
authors.initials: E
authors.lastname: Brouwers
authors.forename: B
authors.initials: B
authors.lastname: Vanloo
authors.forename: M
authors.initials: M
authors.lastname: Rosseneu
authors.forename: D
authors.initials: D
authors.lastname: Collen
mesh_terms: D015060:1,2-Dipalmitoylphosphatidylcholine / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D016632:Apolipoprotein A-I / Q000302:isolation & purification / Q000378:metabolism; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D001692:Biological Transport / Q000187:drug effects; D002340:Carotid Artery Diseases / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D002460:Cell Line; D002788:Cholesterol Esters / Q000378:metabolism; D016894:Endarterectomy, Carotid; D005487:Foam Cells / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism*; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008565:Membrane Proteins; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D011485:Protein Binding; D011971:Receptors, Immunologic / Q000187:drug effects / Q000378:metabolism*; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D013329:Structure-Activity Relationship
chemical_list: D000911:Antibodies, Monoclonal; D016632:Apolipoprotein A-I; D002788:Cholesterol Esters; D008077:Lipoproteins, LDL; D008565:Membrane Proteins; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D015060:1,2-Dipalmitoylphosphatidylcholine